ClinicalTrials.Veeva

Menu

Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer (TEP Margins)

C

Centre Henri Becquerel

Status

Enrolling

Conditions

Head & Neck Cancer

Treatments

Device: micro PET/CT

Study type

Interventional

Funder types

Other

Identifiers

NCT07285564
CHB25.06

Details and patient eligibility

About

The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).

Full description

In approximately 20% of cases, surgical margins are considered insufficient. The only tool currently available intraoperatively to assess the quality of surgical resection is the extemporaneous examination. This has a sensitivity of only 10%.

The objective is therefore to evaluate the performance of another tool, available intraoperatively, to help surgeons assess the quality of their resection. Currently, micro-PET-CT allows for the evaluation of surgical specimens (CE marking and FDA approval obtained). Its performance in the evaluation of surgical margins remains to be demonstrated. This is the subject of the present study.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signed informed consent
  • Adult, male or female, aged 18 or over
  • Patient with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, regardless of lymph node status (any N) M0, operable
  • Member or beneficiary of a social security plan

Exclusion criteria

  • Child-Pugh C liver failure
  • Patients under guardianship, conservatorship, or legal protection
  • Patients deprived of their liberty
  • Pregnant or breastfeeding women
  • Hypersensitivity to 18F-FDG or any of its excipients (ethanol or water for injection)
  • Uncontrolled diabetes
  • Moderate to end-stage renal failure, stage IIIB to V (glomerular filtration rate less than 44 mL/min/1.73 m²)
  • Patients unable to understand the study for any reason or to comply with the trial requirements (language, psychological, or geographical issues).

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Experimental
Experimental group
Description:
PET/CT of the specimen after surgery
Treatment:
Device: micro PET/CT

Trial contacts and locations

1

Loading...

Central trial contact

Lise-Marie Roussel, MD; Doriane Richard, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems